nostaining with tau and MAP2 antibodies, and found (chlorophenylthio-cAMP) (200 M) did not promote axon growth. However, RGC axon growth in response to that all presumptive axons with typical thin morphology stained with tau and were MAP2 negative, whereas pre-BDNF or other peptide trophic factors was greatly potentiated by cAMP elevation, by nearly 7-fold (Figure sumptive dendrites with typical thicker morphology were MAP2 positive. Because developing and regener-3B). This was not limited to a particular developmental window, as RGCs purified from embryonic E20 and adult ating RGCs must extend a single axon over long distances through the optic nerve and tract, we measured P21 rats showed a similar dependence on cAMP elevation to enhance trophic responsiveness (data not the length of the longest axon on each neuron after 3 days in culture, although some RGCs extended more shown). Thus peptide trophic factors signal RGCs to extend axons, but RGCs are poorly responsive to these than one axon from their cell bodies.
We first asked whether single peptide trophic factors peptides unless they are simultaneously signaled by cAMP elevation. would be sufficient to induce axon growth. Only a very slow rate of axon growth could be elicited by BDNF (50 We next asked whether a neuron's axon growth response and survival response to the same peptide trong/ml) alone ( Figure 3B) or by a large variety of other peptide trophic factors that we tested. Because we prephic signal showed the same dosage sensitivity. We investigated the relative ability of a single neurotrophin, viously found that peptide trophic factors were insufficient to promote RGC survival unless the cells were BDNF, to elicit two separate biological functions in the same neurons, survival and axon growth. RGCs were signaled to be responsive by cAMP elevation, we next tested the effects of cAMP elevation. The adenylate cultured in the presence of forskolin and increasing concentrations of BDNF, in two conditions: after infection cyclase activator, forskolin (5 M), profoundly elevates cAMP in purified RGCs (Shen et al., 1999), but was not with adeno-bcl-2, to test axon growth independent of survival, or after infection with adeno-GFP, to test sursufficient to induce axon growth on its own ( Figure 3B) . Similarly, the nondegradable cAMP analog CPT-cAMP vival. The concentrations of BDNF that elicited half maxi-mal axon extension and survival were nearly identical at about 1-2 ng/ml ( Figure 3C ). Many peptide factors other than BDNF were able to induce axon outgrowth in RGCs in the presence of cAMP elevation (Table 1) . We found that every peptide trophic factor that supports RGC survival was also able to induce some axon growth (Meyer-Franke et al., 1995). For instance, CNTF and LIF (leukemia inhibitory factor) strongly promoted survival and also strongly promoted growth. We found that RGCs extended axons equally well in response to BDNF and CNTF or LIF (Table 1) . IGF-1 (insulin-like growth factor 1), which supports RGC survival about half as well as BDNF or CNTF (MeyerFranke et al., 1995), similarly induced approximately half the axon growth (Table 1) . However, although the three peptide factors together elicit approximately additive survival rates (Meyer-Franke et al., 1995), the combination of BDNF, CNTF, and IGF-1 (or insulin) promoted a rate of growth faster than any of these alone, but much less than additive (Table 1) . FGF-1 and -2, which have been widely reported to be strong axon growth stimulants (Lipton et al., 1988), were not very potent in stimulating axon growth in purified RGCs in the absence of other trophic signals (Table 1) . FGFs (fibroblast growth factors) did potentiate both axon growth and survival in the presence of BDNF, however (data not shown). Interestingly, we found one factor, GDNF (glial-derived neurotrophic factor), which supported axon growth although it had no effect on RGC survival (Table 1) . Thus, amongst a large variety of identified neurotrophic factors tested, BDNF and CNTF/LIF most strongly promoted axon growth, and combined together were even more effective.
Effects of Matrix Molecules on Axon Growth
Extracellular matrix molecules promote axon growth, but it is not known whether they are sufficient to induce growth on their own. To investigate this possibility, we next studied the ability of various extracellular matrix molecules to induce axon growth from purified P8 RGCs cultured at clonal density in the absence of added neurotrophic support. Extracellular matrix molecules used as a culture substrate, including laminin-1, merosin, collagen III, collagen IV, and the rich basement membrane matrix Matrigel, were each insufficient to induce significant axon growth on their own (Table 1) . When these signals were added to the culture medium in soluble form, instead of being used as a substrate, they similarly did not induce axon growth (data not shown). When we examined the axon growth-promoting abilities of the cell-adhesion signaling molecules L1 or N-cadherin, or the axon guidance molecule netrin-1, there was similarly little effect (Table 1) .
Laminin has previously been reported to enhance the was enhanced to over 4-fold when cAMP levels were We focused on E18 RGCs, an age when RGCs are norelevated with forskolin ( Figure 3E . To find out whether medium conditioned by retiactivity regulates axon growth, we first investigated whether depolarization induced by high levels of extranal, optic nerve, or superior collicular target cells would also promote axon growth, we cultured purified E20 cellular K ϩ (40 mM) would potentiate axon growth stimulated by BDNF and other trophic factors. We found that RGCs in serum-free medium conditioned by cells isolated from these three tissues (see Experimental Procedepolarization mimicked the ability of cAMP elevation to potentiate BDNF-stimulated axon growth ( Figure 5A ). dures) and measured axon length after 3 days. RGC axon growth was strongly stimulated by target cells, but This potentiation was abolished by the protein kinase A inhibitors Rp-cAMP and H89. Thus, prolonged deporemarkably we found that axon growth was equally well induced by retinal and optic nerve conditioned medium larization potentiates BDNF-induced axon growth, and does so by elevating cAMP. as well. To find out specifically which cell types secreted this axon growth activity, we next tested medium condiBoth depolarization and cAMP elevation rapidly increase surface levels of the BDNF receptor TrkB on tioned by purified optic nerve cell types. We found that optic nerve astrocytes and their precursor cells, as well neuronal somas, axons, and growth cones within minutes (Meyer-Franke et al., 1998). If cAMP elevates BDNF as oligodendrocytes and their precursor cells, all strongly promoted axon growth ( Figure 4B) . responsiveness by increasing TrkB receptors at the surface, then forcing TrkB surface expression should be Because so many peptide factors and conditioned media were sufficient to promote axon outgrowth in sufficient to enhance responsiveness in the absence of cAMP elevation. To test this hypothesis, we increased RGCs, we hypothesized that one or a few signaling pathways might provide a common downstream mechanism TrkB expression by using an adenoviral vector that pro- . Thus, we used direct electrical stimulation to test whether it sponsiveness was also observed: in the presence of BDNF, TrkB increased survival from 4% Ϯ 2% to 38% Ϯ would similarly enhance axon growth in response to peptide trophic factors. We cultured RGCs on silicon 5% (mean Ϯ SEM). TrkB overexpression did not, however, increase axon growth significantly in the presence chips containing multiple electrodes through which we could apply field stimulation ( Figure 7A ; Borkholder et of cAMP elevation. These results show that elevation of surface levels of TrkB is sufficient to fully mimic the al., 1997). We used a stimulation protocol that closely mimicked the physiologic activity RGCs experience norability of cAMP elevation to enhance BDNF responsiveness. mally during the embryonic and early postnatal period, characterized by short bursts of action potentials separated by periods of relative silence ( Figure 7A ). RGCs Role of Physiological Levels of Activity in Stimulating Axon Growth were visualized by labeling with DiI ( Figure 7B ) and their survival was confirmed by labeling with calcein. ElectriTo investigate whether more physiologic levels of activity would affect axon outgrowth, we took three apcal stimulation on its own had no effect on RGC survival or axon growth in the absence of peptide trophic factors proaches. First, we asked whether intermittent depolarization by elevated K ϩ over the course of several hours (data not shown). Remarkably, we found that even these very low levels of electrical stimulation profoundly poincreased axon outgrowth in response to BDNF. We visualized RGCs using time lapse microscopy and aptentiated RGC axon growth ( Figures 7B and 7C ) and survival ( Figures 7D and 7E ) in response to peptide facplied short, 0.5 s pulses of 40 mM KCl to the bath once every 2 min to mimic the approximate time course of tors. SQ22536, an adenylate cyclase inhibitor, or TTX (tetrodotoxin) largely blocked the ability of physiologic their excitation in the developing retina (Wong et al., 1993, 1998). We loaded RGCs with the calcium indicator stimulation to enhance responsiveness to peptide trophic factors, although these only slightly affected basedye fura-2 and found that RGCs remained responsive to intermittent depolarizing stimuli by fluxing calcium in line levels of BDNF-induced axon growth in the absence of stimulation ( Figure 7C ). We repeated these experiresponse to KCl pulses over the course of hours ( Figure  6A ). When we measured axon growth in bath-applied ments using RGCs purified from embryonic day 19-20 rats, a developmental age at which RGCs are still nortrophic factors with and without intermittent KCl depolarization, we found that intermittent KCl stimulation dramally extending their axons toward their targets in vivo. Embryonic RGCs cultured in the presence of BDNF matically potentiated peptide factor-induced axon growth ( Figure 6B) .
showed a similar 6-fold enhancement of axon length in response to electrical stimulation, which was both acIn our second approach, we examined the effect of stimulating RGCs in culture to fire action potentials in tion potential (TTX) and cAMP (SQ) dependent (data not shown). These results show that physiological levels of a pattern similar to their normal activity in embryonic retina. RGCs are normally electrically active before phoelectrical activity promote peptide factor-induced out- the filters ( Figure 8A ). However, BDNF-induced axon extension was reduced 3-fold in the presence of a cockDiscussion tail of activity blockers including TTX, curare, and kynurenic acid (Figures 8B and 8C) , or in the presence of the Retinal Ganglion Cells Do Not Extend Axons by Default adenylate cyclase inhibitor SQ22536 or the PKA (protein kinase A) inhibitor Rp-cAMP ( Figure 8C ). In the presence By elevating expression of the anti-apoptotic gene bcl-2 in RGCs, we found that we could separate the ability of of activity blockade or of adenylate cyclase inhibition, the nonhydrolyzable cAMP analog CPT-cAMP rescued a neuron to survive from its ability to extend axons. Bcl-2 overexpression alone prevented RGCs from undergoing axon extension from the explants, although CPT-cAMP could not induce any outgrowth on its own ( Figure 8C) . apoptosis when cultured in the complete absence of neurotrophic signals. These bcl-2-overexpressing RGCs When we repeated these experiments with embryonic retinas, we obtained the same result (data not shown). failed to elaborate axons or dendrites despite maintenance of a normal soma size. These data demonstrate These data demonstrate that endogenous levels of synaptic and electrical activity enhance retinal axon growth that surviving neurons do not extend axons by default and show that axon growth must be specifically sigin response to BDNF. These data also provide a model system in which the extracellular signals that normally promote axon growth can be elucidated, as well as the intracellular mechanisms by which they act. Importantly, the vast majority of embryonic and postnatal RGCs that we studied had already initiated dendritic and axonal growth in vivo before the time of isolation. Although the neuronal purification shears off axons and dendrites, typically RGCs retain a remnant of the axon and dendrite hillocks (our unpublished observations). Thus our studies focus specifically on the mechanisms that induce axonal elonga- ance (Hopker et al., 1999) , whereas the effect of elevattheir axons as they travel together along the visual pathway during development. As E17 RGCs do not respond ing cAMP is to globally increase neurotrophin responsiveness and thereby to activate a generalized program to any of the so far identified trophic peptides, yet their growth is strongly stimulated by APCs and target cells, of axon growth at the growth cone, along the axon, and at the cell soma.
it is likely that important axon growth-stimulating signals for RGCs remain to be identified. In contrast to matrix molecules, we found that single neurotrophins and other peptide trophic factors were sufficient to induce robust axon growth on their own.
Physiological Levels of Activity Profoundly Recent studies have suggested that CNTF is better able Enhance Axon Growth by Enhancing to induce axon growth and regeneration than BDNF is Neurotrophic Responsiveness of RGCs in vitro and in vivo (Cui et al., 1999; Jo et al., 1999) . Our
We found that electrical activity dramatically enhanced studies show that BDNF and CNTF have the same ability the rate of trophic factor-stimulated axon growth by to directly signal axon outgrowth by RGCs. The differRGCs both in vitro and within retinal explants. Little ences between our findings and previous reports could axonal growth was elicited by peptide neurotrophic facbe accounted for by a differential ability of CNTF and tors unless the cells were electrically active or their intra-BDNF to signal glial cells to promote or inhibit axon cellular levels of cAMP were elevated pharmacologigrowth and indirectly mediate trophic effects in vivo cally. Most striking was that, for RGCs cultured directly (Harada et al., 2000) .
on silicon chips through which we could control the Given that the signaling mechanisms that promote cell level and pattern of activity, exceedingly low levels of survival and axon growth differ, as for instance shown by electrical stimulation, comprised of short bursts once the ability of bcl-2 to promote cell survival but not axon every minute, were sufficient to dramatically potentiate outgrowth, it is remarkable that the same peptides that axon growth and survival in response to peptide neuromost strongly promote cell survival are generally the trophic factors, although activity on its own had no efsame ones that most strongly promote axon growth. . Postsynaptic CPG15 promotes synaptic maturation and presynaptic axon arbor elaboraretinae was counted after 3 days in culture. tion in vivo. Nat. Neurosci. 3, 1004-1011.
